Crown Laboratories Acquires Bellus Medical

October 12, 2018

Specialty pharmace­utical company Crown Laboratories, Inc. and portfolio company Hildred Capital Partners LLC (Hildred) have announced the acquisition of Bellus Medical.
Bellus Medical specializes in medical aesthetic treatments, delivering repairing and restorative products to aesthetic practices around the globe. Its range of products include SkinPen, a medical grade microneedling device used exclusively by healthcare providers to improve the appearance of facial acne scars.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
    • CBS News Investigation Raises Concerns About Unapproved Retatrutide Sales
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform